14.23 USD
-0.17 (-1.18%)
Overall OFIX gets a fundamental rating of 2 out of 10. We evaluated OFIX against 185 industry peers in the Health Care Equipment & Supplies industry. OFIX has a bad profitability rating. Also its financial health evaluation is rather negative. OFIX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year OFIX has reported negative net income.
- OFIX had a positive operating cash flow in the past year.
- OFIX had negative earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: OFIX reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of -14.31%, OFIX perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
- OFIX has a Return On Equity (-26.92%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.31% | ||
| ROE | -26.92% | ||
| ROIC | N/A |
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- OFIX's Gross Margin of 68.27% is fine compared to the rest of the industry. OFIX outperforms 74.05% of its industry peers.
- OFIX's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for OFIX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
- OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for OFIX has been increased compared to 1 year ago.
- The number of shares outstanding for OFIX has been increased compared to 5 years ago.
- Compared to 1 year ago, OFIX has a worse debt to assets ratio.
2.2 Solvency
- OFIX has an Altman-Z score of 1.23. This is a bad value and indicates that OFIX is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.23, OFIX is in line with its industry, outperforming 52.43% of the companies in the same industry.
- OFIX has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of OFIX (0.39) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.23 |
ROIC/WACCN/A
WACC9.59%
2.3 Liquidity
- A Current Ratio of 2.47 indicates that OFIX has no problem at all paying its short term obligations.
- The Current ratio of OFIX (2.47) is comparable to the rest of the industry.
- A Quick Ratio of 1.38 indicates that OFIX should not have too much problems paying its short term obligations.
- The Quick ratio of OFIX (1.38) is worse than 61.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- OFIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10900.00%.
- Measured over the past years, OFIX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.14% on average per year.
- OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.31%.
- OFIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.69% yearly.
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%
3.2 Future
- OFIX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -443.00% yearly.
- Based on estimates for the next years, OFIX will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y-23152%
EPS Next 2Y-1428.2%
EPS Next 3Y-443%
EPS Next 5YN/A
Revenue Next Year2.31%
Revenue Next 2Y4.06%
Revenue Next 3Y4.76%
Revenue Next 5Y4.62%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for OFIX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OFIX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- OFIX's earnings are expected to decrease with -443.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1428.2%
EPS Next 3Y-443%
5. Dividend
5.1 Amount
- No dividends for OFIX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:OFIX (1/16/2026, 12:07:17 PM)
14.23
-0.17 (-1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners91.28%
Inst Owner Change0.01%
Ins Owners1.4%
Ins Owner Change-0.05%
Market Cap563.51M
Revenue(TTM)818.06M
Net Income(TTM)-119.12M
Analysts85.45
Price Target23.26 (63.46%)
Short Float %2.95%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.73%
Min EPS beat(2)-37.41%
Max EPS beat(2)9.96%
EPS beat(4)3
Avg EPS beat(4)47.99%
Min EPS beat(4)-37.41%
Max EPS beat(4)139.22%
EPS beat(8)7
Avg EPS beat(8)81.32%
EPS beat(12)11
Avg EPS beat(12)87.39%
EPS beat(16)13
Avg EPS beat(16)57.92%
Revenue beat(2)2
Avg Revenue beat(2)0.97%
Min Revenue beat(2)0.8%
Max Revenue beat(2)1.14%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)-1.67%
Revenue beat(16)5
Avg Revenue beat(16)-1.56%
PT rev (1m)0%
PT rev (3m)1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-57.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.69 | ||
| P/FCF | N/A | ||
| P/OCF | 19.18 | ||
| P/B | 1.27 | ||
| P/tB | 3.28 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.08
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.74
OCFY5.21%
SpS20.66
BVpS11.17
TBVpS4.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.31% | ||
| ROE | -26.92% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.27% | ||
| FCFM | N/A |
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 40.23% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 1.23 |
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
EPS Next Y-23152%
EPS Next 2Y-1428.2%
EPS Next 3Y-443%
EPS Next 5YN/A
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%
Revenue Next Year2.31%
Revenue Next 2Y4.06%
Revenue Next 3Y4.76%
Revenue Next 5Y4.62%
EBIT growth 1Y-2.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.97%
EBIT Next 3Y51.04%
EBIT Next 5Y38.14%
FCF growth 1Y96.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.14%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%
ORTHOFIX MEDICAL INC / OFIX FAQ
Can you provide the ChartMill fundamental rating for ORTHOFIX MEDICAL INC?
ChartMill assigns a fundamental rating of 2 / 10 to OFIX.
What is the valuation status of ORTHOFIX MEDICAL INC (OFIX) stock?
ChartMill assigns a valuation rating of 0 / 10 to ORTHOFIX MEDICAL INC (OFIX). This can be considered as Overvalued.
Can you provide the profitability details for ORTHOFIX MEDICAL INC?
ORTHOFIX MEDICAL INC (OFIX) has a profitability rating of 2 / 10.
How financially healthy is ORTHOFIX MEDICAL INC?
The financial health rating of ORTHOFIX MEDICAL INC (OFIX) is 3 / 10.